{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:32:07Z","timestamp":1759617127815},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jphs.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T10:30:36Z","timestamp":1498041036000},"page":"175-180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pregabalin reduces cisplatin-induced mechanical allodynia in rats"],"prefix":"10.1016","volume":"134","author":[{"given":"Yoshihiro","family":"Seto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2017.06.003_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/bjc.1986.237","article-title":"Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck","volume":"54","author":"Thyss","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/bjc.1990.135","article-title":"A\u00a0randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer","volume":"61","author":"Woods","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjc.6600002","article-title":"Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer","volume":"86","author":"van der Burg","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib4","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjc.6601616","article-title":"Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients","volume":"90","author":"Ezzat","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib5","first-page":"199","article-title":"Cisplatin neuropathy: clinical course and neurophysiological findings","volume":"239","author":"LoMonaco","year":"1992","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jphs.2017.06.003_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1566-0702(00)00247-2","article-title":"Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis","volume":"86","author":"Aloe","year":"2000","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jphs.2017.06.003_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"McLeod HL Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jphs.2017.06.003_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/FBP.0000000000000090","article-title":"Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain","volume":"25","author":"Han","year":"2014","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jphs.2017.06.003_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(02)00047-7","article-title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","volume":"98","author":"Hammack","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2017.06.003_bib10","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib11","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/cncr.23482","article-title":"Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3","volume":"112","author":"Rao","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00520-010-1018-3","article-title":"The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial","volume":"19","author":"Kottschade","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1211\/0022357001777360","article-title":"Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats","volume":"52","author":"Kobayashi","year":"2000","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jphs.2017.06.003_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1081\/CBI-100107520","article-title":"Cisplatin-induced vomiting depends on circadian timing","volume":"18","author":"Kobayashi","year":"2001","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.jphs.2017.06.003_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.113.089805","article-title":"Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice","volume":"85","author":"Oda","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2017.06.003_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12885-016-2777-0","article-title":"Influence of dosing times on cisplatin-induced peripheral neuropathy in rats","volume":"16","author":"Seto","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jphs.2017.06.003_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11940-010-0108-3","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Cavaletti","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jphs.2017.06.003_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/AJP.0000000000000198","article-title":"Efficacy and safety of pregabalin in the treatment of patients with painful diabetic peripheral neuropathy and pain on walking","volume":"31","author":"Huffman","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jphs.2017.06.003_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin\u2013a meta-analysis of randomized controlled trials","volume":"145","author":"Hauser","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2017.06.003_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2017.06.003_bib21","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin","volume":"29","author":"Bauer","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jphs.2017.06.003_bib22","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin","volume":"103","author":"Field","year":"2006","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.jphs.2017.06.003_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.111.187401","article-title":"Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia","volume":"342","author":"Ito","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2017.06.003_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cbi.2015.06.025","article-title":"Tetrahydrocurcumin exerts protective effect on vincristine induced neuropathy: behavioral, biochemical, neurophysiological and histological evidence","volume":"238","author":"Greeshma","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jphs.2017.06.003_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jphs.2015.08.006","article-title":"Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats","volume":"129","author":"Yamamoto","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2017.06.003_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuropharm.2008.06.007","article-title":"Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection","volume":"55","author":"Ling","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jphs.2017.06.003_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pbb.2014.03.025","article-title":"Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice","volume":"122","author":"Salat","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jphs.2017.06.003_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(00)01373-2","article-title":"Assessment of allodynia and hyperalgesia after cisplatin administration to rats","volume":"291","author":"Authier","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphs.2017.06.003_bib29","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/ALN.0000000000000190","article-title":"Chemokine (C-C motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain","volume":"120","author":"Matsushita","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jphs.2017.06.003_bib30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1213\/ANE.0b013e31825d2ad1","article-title":"The immunomodulatory effect of pregabalin on spleen cells in neuropathic mice","volume":"115","author":"Jang","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jphs.2017.06.003_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Nugent K Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jphs.2017.06.003_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Go","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jphs.2017.06.003_bib33","first-page":"1","article-title":"The safety of pregabalin in the treatment of fibromyalgia","author":"Gerardi","year":"2016","journal-title":"Expert Opin drug Saf"},{"key":"10.1016\/j.jphs.2017.06.003_bib34","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","article-title":"Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy","volume":"27","author":"Dzagnidze","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jphs.2017.06.003_bib35","first-page":"64","article-title":"The effect of pregabalin and celecoxib on the analgesic requirements after laparoscopic cholecystectomy: a randomized controlled trial","volume":"30","author":"Gurunathan","year":"2016","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.jphs.2017.06.003_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317300865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317300865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T15:29:02Z","timestamp":1535729342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861317300865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1347861317300865"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2017.06.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregabalin reduces cisplatin-induced mechanical allodynia in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}